TipRanks
Alkermes (DE:8AK)
XETRA:8AK

Compare Alkermes (8AK) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Alkermes
€42.13
€6.79B
112.51
51.08%
8 Buy
3 Hold
1 Sell
Moderate Buy
Dr Reddy's Laboratories
$12.22
$11.87B
40.24
5.35%
2 Buy
1 Hold
0 Sell
Moderate Buy
Viatris
$16.72
$21.86B
-52.88
83.74%
5 Buy
3 Hold
1 Sell
Moderate Buy
Supernus Pharmaceuticals
$45.36
$2.44B
-55.06
-25.81%
2 Buy
1 Hold
0 Sell
Moderate Buy
Indivior
$35.97
$4.17B
9.66
21.42%
3 Buy
0 Hold
0 Sell
Strong Buy
Takeda Pharmaceutical Company
$18.23
$67.37B
27.16
58.05%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:8AK
Alkermes
40.49
14.09
53.37%
RDY
Dr Reddy's Laboratories
14.17
0.95
7.21%
VTRS
Viatris
19.04
9.03
90.25%
SUPN
Supernus Pharmaceuticals
41.92
-13.21
-23.96%
INDV
Indivior
35.37
6.00
20.43%
TAK
Takeda Pharmaceutical Company
20.91
7.47
55.58%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts